However, there have also been studies indicating that an increased expression of TG2 may prolong cell survival by preventing apoptosis as TG2 causes the constitutive activation of NF-KB in cancer cells and TG2 could be an attractive alternate target for inhibiting constitutive NF-KB activation and rendering cancer cells sensitive to anticancer drugs [50]. This evidence concerns the gene NFKB1 and cancer.